Safety and immunogenicity of the Mycobacterium tuberculosis ΔlysA ΔpanCD vaccine in domestic cats infected with feline immunodeficiency virus

Dawn M. Zimmerman, W. Ray Waters, Konstantin P. Lyashchenko, Brian J. Nonnecke, Douglas L. Armstrong, William R. Jacobs, Michelle H. Larsen, Erin Egan, Gregg A. Dean

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Feline immunodeficiency virus (FIV)-positive and FIV-negative cats (n = 4/group) received 2 × 106 CFU Mycobacterium tuberculosis ΔlysA ΔpanCD intramuscularly. Vaccination elicited antibody responses, albeit at lower levels in FIV-positive cats than in FIV-negative cats. Delayed-type hypersensitivity responses were minimal in both groups. No adverse reactions were found.

Original languageEnglish (US)
Pages (from-to)427-429
Number of pages3
JournalClinical and Vaccine Immunology
Volume16
Issue number3
DOIs
StatePublished - Mar 2009

Fingerprint

Feline Immunodeficiency Virus
Viruses
Mycobacterium tuberculosis
Cats
Vaccines
Safety
Delayed Hypersensitivity
Antibody Formation
Vaccination
Antibodies

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Immunology
  • Immunology and Allergy
  • Microbiology (medical)

Cite this

Safety and immunogenicity of the Mycobacterium tuberculosis ΔlysA ΔpanCD vaccine in domestic cats infected with feline immunodeficiency virus. / Zimmerman, Dawn M.; Waters, W. Ray; Lyashchenko, Konstantin P.; Nonnecke, Brian J.; Armstrong, Douglas L.; Jacobs, William R.; Larsen, Michelle H.; Egan, Erin; Dean, Gregg A.

In: Clinical and Vaccine Immunology, Vol. 16, No. 3, 03.2009, p. 427-429.

Research output: Contribution to journalArticle

Zimmerman, Dawn M. ; Waters, W. Ray ; Lyashchenko, Konstantin P. ; Nonnecke, Brian J. ; Armstrong, Douglas L. ; Jacobs, William R. ; Larsen, Michelle H. ; Egan, Erin ; Dean, Gregg A. / Safety and immunogenicity of the Mycobacterium tuberculosis ΔlysA ΔpanCD vaccine in domestic cats infected with feline immunodeficiency virus. In: Clinical and Vaccine Immunology. 2009 ; Vol. 16, No. 3. pp. 427-429.
@article{caf5d994b8cc4efbbb87951ea81c63f8,
title = "Safety and immunogenicity of the Mycobacterium tuberculosis ΔlysA ΔpanCD vaccine in domestic cats infected with feline immunodeficiency virus",
abstract = "Feline immunodeficiency virus (FIV)-positive and FIV-negative cats (n = 4/group) received 2 × 106 CFU Mycobacterium tuberculosis ΔlysA ΔpanCD intramuscularly. Vaccination elicited antibody responses, albeit at lower levels in FIV-positive cats than in FIV-negative cats. Delayed-type hypersensitivity responses were minimal in both groups. No adverse reactions were found.",
author = "Zimmerman, {Dawn M.} and Waters, {W. Ray} and Lyashchenko, {Konstantin P.} and Nonnecke, {Brian J.} and Armstrong, {Douglas L.} and Jacobs, {William R.} and Larsen, {Michelle H.} and Erin Egan and Dean, {Gregg A.}",
year = "2009",
month = "3",
doi = "10.1128/CVI.00396-08",
language = "English (US)",
volume = "16",
pages = "427--429",
journal = "Clinical and Vaccine Immunology",
issn = "1556-6811",
publisher = "American Society for Microbiology",
number = "3",

}

TY - JOUR

T1 - Safety and immunogenicity of the Mycobacterium tuberculosis ΔlysA ΔpanCD vaccine in domestic cats infected with feline immunodeficiency virus

AU - Zimmerman, Dawn M.

AU - Waters, W. Ray

AU - Lyashchenko, Konstantin P.

AU - Nonnecke, Brian J.

AU - Armstrong, Douglas L.

AU - Jacobs, William R.

AU - Larsen, Michelle H.

AU - Egan, Erin

AU - Dean, Gregg A.

PY - 2009/3

Y1 - 2009/3

N2 - Feline immunodeficiency virus (FIV)-positive and FIV-negative cats (n = 4/group) received 2 × 106 CFU Mycobacterium tuberculosis ΔlysA ΔpanCD intramuscularly. Vaccination elicited antibody responses, albeit at lower levels in FIV-positive cats than in FIV-negative cats. Delayed-type hypersensitivity responses were minimal in both groups. No adverse reactions were found.

AB - Feline immunodeficiency virus (FIV)-positive and FIV-negative cats (n = 4/group) received 2 × 106 CFU Mycobacterium tuberculosis ΔlysA ΔpanCD intramuscularly. Vaccination elicited antibody responses, albeit at lower levels in FIV-positive cats than in FIV-negative cats. Delayed-type hypersensitivity responses were minimal in both groups. No adverse reactions were found.

UR - http://www.scopus.com/inward/record.url?scp=61949096795&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=61949096795&partnerID=8YFLogxK

U2 - 10.1128/CVI.00396-08

DO - 10.1128/CVI.00396-08

M3 - Article

C2 - 19144788

AN - SCOPUS:61949096795

VL - 16

SP - 427

EP - 429

JO - Clinical and Vaccine Immunology

JF - Clinical and Vaccine Immunology

SN - 1556-6811

IS - 3

ER -